Multiple Sclerosis Clinical Trial
Official title:
Clinical Pilot Study in the Feasibility and Effect of Online Cognitive Training on Cognitive Functions in Patients With Parkinson's Disease, Multiple Sclerosis and Depressive Patients Treated With Electroconvulsive Therapy
In Parkinson's disease, Multiple Sclerosis and depressed patients treated with
electroconvulsive therapy, cognitive dysfunction is prevalent. However, treatment of these
dysfunctions is in its infancy.
The purpose of this study is 1) to assess the feasibility of a randomized controlled trial
using an online computerized intervention for training cognitive abilities in the three
patient groups and 2) to estimate the effect of the online training on objectively and
subjectively measured cognitive functions.
The investigators hypothesize that patients using online cognitive training will improve more
on cognitive functions, as compared to patients using an active control condition.
In neurodegenerative disorders and psychiatric disorders, cognitive dysfunction is frequently
reported. In Parkinson's disease (PD), Multiple Sclerosis (MS) and patients treated with
electroconvulsive therapy after a severe or therapy resistant depression (postECT), executive
dysfunction, attention deficit or episodic/autobiographic memory deficit is prevalent. In MS
and PD, these dysfunctions can appear already early in the disease. The majority of PD
patients - lifetime prevalence is about 80% - develops PD dementia. In MS, about half of the
patients experiences problems with cognitive functions. ECT is used to treat patients with
severe and/or therapy resistant depression. However, 30-50% of these patients develops severe
cognitive dysfunction. Recovery usually occurs within six months after ECT. However,
performances remain below-average compared to norm groups and there are large individual
differences. The cognitive difficulties in MS and PD have a significant negative influence on
the quality of life. Cognitive dysfunction in PD is associated with decreased independent
daily functioning, hospitalization and the development and severity of neuropsychiatric
symptoms. Furthermore, in the clinic cognitive dysfunction has been reported to be one of the
most dreadful side effects of ECT. However, effective treatment of the described cognitive
dysfunction is still in its infancy.
Cognitive training is based upon the principle that plasticity of the brain can facilitate
function improvement by intensive training. In several neurological diseases, cognitive
training has shown significant improvement in cognitive functions. In MS and PD, earlier
studies have been small, frequently without an adequately controlled design. Additionally,
earlier cognitive training programs have frequently been executed in a health care
organization, impairing patients to successfully attend all training sessions due to mobility
impairments. Also, there are limited studies in the effects of cognitive training on improved
functioning of daily living and neuropsychiatric symptoms like anxiety and depression. Given
the fact that there is an absence in cognitive training studies in patients post-ECT, there
is no knowledge about the ability of cognitive training to speed up the natural course.
Using this pilot study, the investigators aim to study the feasibility of a randomized
controlled trial using an online computerized intervention for training cognitive abilities
in three patient groups. By using a double-blinded, controlled study design, the
investigators keep in mind limitations of earlier comparable studies. If this treatment
proves to be feasible, and a rough estimated effect size is positive, a larger randomized
controlled trial can be executed to study the effectivity of this treatment. When effects are
positive, an online cognitive training programme could prove to be a cost-efficient
intervention that is accessible at home - something which is important for patients with
mobility problems. The investigators hypothesize that patients using online cognitive
training will improve more on cognitive functions, as compared to patients using an active
training condition.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |